Anti-hypertensive drugs have different effects on ventricular hypertrophy regression

Detalhes bibliográficos
Autor(a) principal: Ferreira Filho, Celso [UNIFESP]
Data de Publicação: 2010
Outros Autores: Abreu, Luiz Carlos de, Valenti, Vitor Engrácia [UNIFESP], Ferreira, Marcelo, Meneghini, Adriano, Silveira, José Alexandre, Perez Riera, Andrés Ricardo [UNIFESP], Colombari, Eduardo [UNIFESP], Murad, Neif, Santos-Silva, Paulo Roberto, Silva, Lovian José Henrique Pereira da, Vanderlei, Luiz Carlos Marques, Carvalho, Tatiana Dias de [UNIFESP], Ferreira, Celso [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S1807-59322010000700012
http://repositorio.unifesp.br/handle/11600/5488
Resumo: OBJECTIVES: There is a direct relationship between the regression of left ventricular hypertrophy (LVH) and a decreased risk of mortality. This investigation aimed to describe the effects of anti-hypertensive drugs on cardiac hypertrophy through a meta-analysis of the literature. METHODS: The Medline (via PubMed), Lilacs and Scielo databases were searched using the subject keywords cardiac hypertrophy, antihypertensive and mortality. We aimed to analyze the effect of anti-hypertensive drugs on ventricle hypertrophy. RESULTS: The main drugs we described were enalapril, verapamil, nifedipine, indapamina, losartan, angiotensin-converting enzyme inhibitors and atenolol. These drugs are usually used in follow up programs, however, the studies we investigated used different protocols. Enalapril (angiotensin-converting enzyme inhibitor) and verapamil (Ca++ channel blocker) caused hypertrophy to regress in LVH rats. The effects of enalapril and nifedipine (Ca++ channel blocker) were similar. Indapamina (diuretic) had a stronger effect than enalapril, and losartan (angiotensin II receptor type 1 (AT1) receptor antagonist) produced better results than atenolol (selective β1 receptor antagonist) with respect to LVH regression. CONCLUSION: The anti-hypertensive drugs induced various degrees of hypertrophic regression.
id UFSP_b3a8754b0f90aeee03ec438c05f08cfb
oai_identifier_str oai:repositorio.unifesp.br/:11600/5488
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Anti-hypertensive drugs have different effects on ventricular hypertrophy regressionHypertrophyCardiomyopathyHypertrophicLeft ventricle hypertensionCardiologyOBJECTIVES: There is a direct relationship between the regression of left ventricular hypertrophy (LVH) and a decreased risk of mortality. This investigation aimed to describe the effects of anti-hypertensive drugs on cardiac hypertrophy through a meta-analysis of the literature. METHODS: The Medline (via PubMed), Lilacs and Scielo databases were searched using the subject keywords cardiac hypertrophy, antihypertensive and mortality. We aimed to analyze the effect of anti-hypertensive drugs on ventricle hypertrophy. RESULTS: The main drugs we described were enalapril, verapamil, nifedipine, indapamina, losartan, angiotensin-converting enzyme inhibitors and atenolol. These drugs are usually used in follow up programs, however, the studies we investigated used different protocols. Enalapril (angiotensin-converting enzyme inhibitor) and verapamil (Ca++ channel blocker) caused hypertrophy to regress in LVH rats. The effects of enalapril and nifedipine (Ca++ channel blocker) were similar. Indapamina (diuretic) had a stronger effect than enalapril, and losartan (angiotensin II receptor type 1 (AT1) receptor antagonist) produced better results than atenolol (selective β1 receptor antagonist) with respect to LVH regression. CONCLUSION: The anti-hypertensive drugs induced various degrees of hypertrophic regression.Faculdade de Medicina do ABC Disciplina de Cardiologia Departamento de Clínica MédicaFaculdade de Medicina do ABC Departamento de Morfologia e FisiologiaUniversidade Federal de São Paulo (UNIFESP) Disciplina de Cardiologia Departamento de MedicinaUniversidade Estadual Paulista Faculdade de Ciências e Tecnologia Departamento de FisioterapiaUNIFESP, Disciplina de Cardiologia Depto. de MedicinaSciELOFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Nucleo de Estudos, Pesquisas e Assessoria a Saude da Faculdade de Medicina do ABC (NEPAS)Faculdade de Medicina / USPFaculdade de Medicina do ABC Disciplina de Cardiologia Departamento de Clínica MédicaFaculdade de Medicina do ABC Departamento de Morfologia e FisiologiaUniversidade Federal de São Paulo (UNIFESP)Universidade Estadual Paulista (UNESP)Ferreira Filho, Celso [UNIFESP]Abreu, Luiz Carlos deValenti, Vitor Engrácia [UNIFESP]Ferreira, MarceloMeneghini, AdrianoSilveira, José AlexandrePerez Riera, Andrés Ricardo [UNIFESP]Colombari, Eduardo [UNIFESP]Murad, NeifSantos-Silva, Paulo RobertoSilva, Lovian José Henrique Pereira daVanderlei, Luiz Carlos MarquesCarvalho, Tatiana Dias de [UNIFESP]Ferreira, Celso [UNIFESP]2015-06-14T13:41:24Z2015-06-14T13:41:24Z2010-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion723-728application/pdfhttp://dx.doi.org/10.1590/S1807-59322010000700012Clinics. Faculdade de Medicina / USP, v. 65, n. 7, p. 723-728, 2010.10.1590/S1807-59322010000700012S1807-59322010000700012.pdf1807-5932S1807-59322010000700012http://repositorio.unifesp.br/handle/11600/5488WOS:000280808400012engClinicsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-06T09:48:58Zoai:repositorio.unifesp.br/:11600/5488Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-06T09:48:58Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
title Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
spellingShingle Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
Ferreira Filho, Celso [UNIFESP]
Hypertrophy
Cardiomyopathy
Hypertrophic
Left ventricle hypertension
Cardiology
title_short Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
title_full Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
title_fullStr Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
title_full_unstemmed Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
title_sort Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
author Ferreira Filho, Celso [UNIFESP]
author_facet Ferreira Filho, Celso [UNIFESP]
Abreu, Luiz Carlos de
Valenti, Vitor Engrácia [UNIFESP]
Ferreira, Marcelo
Meneghini, Adriano
Silveira, José Alexandre
Perez Riera, Andrés Ricardo [UNIFESP]
Colombari, Eduardo [UNIFESP]
Murad, Neif
Santos-Silva, Paulo Roberto
Silva, Lovian José Henrique Pereira da
Vanderlei, Luiz Carlos Marques
Carvalho, Tatiana Dias de [UNIFESP]
Ferreira, Celso [UNIFESP]
author_role author
author2 Abreu, Luiz Carlos de
Valenti, Vitor Engrácia [UNIFESP]
Ferreira, Marcelo
Meneghini, Adriano
Silveira, José Alexandre
Perez Riera, Andrés Ricardo [UNIFESP]
Colombari, Eduardo [UNIFESP]
Murad, Neif
Santos-Silva, Paulo Roberto
Silva, Lovian José Henrique Pereira da
Vanderlei, Luiz Carlos Marques
Carvalho, Tatiana Dias de [UNIFESP]
Ferreira, Celso [UNIFESP]
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Faculdade de Medicina do ABC Disciplina de Cardiologia Departamento de Clínica Médica
Faculdade de Medicina do ABC Departamento de Morfologia e Fisiologia
Universidade Federal de São Paulo (UNIFESP)
Universidade Estadual Paulista (UNESP)
dc.contributor.author.fl_str_mv Ferreira Filho, Celso [UNIFESP]
Abreu, Luiz Carlos de
Valenti, Vitor Engrácia [UNIFESP]
Ferreira, Marcelo
Meneghini, Adriano
Silveira, José Alexandre
Perez Riera, Andrés Ricardo [UNIFESP]
Colombari, Eduardo [UNIFESP]
Murad, Neif
Santos-Silva, Paulo Roberto
Silva, Lovian José Henrique Pereira da
Vanderlei, Luiz Carlos Marques
Carvalho, Tatiana Dias de [UNIFESP]
Ferreira, Celso [UNIFESP]
dc.subject.por.fl_str_mv Hypertrophy
Cardiomyopathy
Hypertrophic
Left ventricle hypertension
Cardiology
topic Hypertrophy
Cardiomyopathy
Hypertrophic
Left ventricle hypertension
Cardiology
description OBJECTIVES: There is a direct relationship between the regression of left ventricular hypertrophy (LVH) and a decreased risk of mortality. This investigation aimed to describe the effects of anti-hypertensive drugs on cardiac hypertrophy through a meta-analysis of the literature. METHODS: The Medline (via PubMed), Lilacs and Scielo databases were searched using the subject keywords cardiac hypertrophy, antihypertensive and mortality. We aimed to analyze the effect of anti-hypertensive drugs on ventricle hypertrophy. RESULTS: The main drugs we described were enalapril, verapamil, nifedipine, indapamina, losartan, angiotensin-converting enzyme inhibitors and atenolol. These drugs are usually used in follow up programs, however, the studies we investigated used different protocols. Enalapril (angiotensin-converting enzyme inhibitor) and verapamil (Ca++ channel blocker) caused hypertrophy to regress in LVH rats. The effects of enalapril and nifedipine (Ca++ channel blocker) were similar. Indapamina (diuretic) had a stronger effect than enalapril, and losartan (angiotensin II receptor type 1 (AT1) receptor antagonist) produced better results than atenolol (selective β1 receptor antagonist) with respect to LVH regression. CONCLUSION: The anti-hypertensive drugs induced various degrees of hypertrophic regression.
publishDate 2010
dc.date.none.fl_str_mv 2010-01-01
2015-06-14T13:41:24Z
2015-06-14T13:41:24Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S1807-59322010000700012
Clinics. Faculdade de Medicina / USP, v. 65, n. 7, p. 723-728, 2010.
10.1590/S1807-59322010000700012
S1807-59322010000700012.pdf
1807-5932
S1807-59322010000700012
http://repositorio.unifesp.br/handle/11600/5488
WOS:000280808400012
url http://dx.doi.org/10.1590/S1807-59322010000700012
http://repositorio.unifesp.br/handle/11600/5488
identifier_str_mv Clinics. Faculdade de Medicina / USP, v. 65, n. 7, p. 723-728, 2010.
10.1590/S1807-59322010000700012
S1807-59322010000700012.pdf
1807-5932
S1807-59322010000700012
WOS:000280808400012
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Clinics
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 723-728
application/pdf
dc.publisher.none.fl_str_mv Faculdade de Medicina / USP
publisher.none.fl_str_mv Faculdade de Medicina / USP
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268405770878976